Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsPharmaceutical Acarbose
PharmaceuticalAntidiabeticAlpha-glucosidase inhibitorCarbohydrate blocker

Acarbose

Also known as Precose · Glucobay

Acarbose (Precose, Glucobay) is an alpha-glucosidase inhibitor that slows intestinal carbohydrate digestion, blunting post-meal glucose and insulin spikes. Bodybuilders use it to reduce fat gain from high-carbohydrate meals. It does not cause hypoglycaemia alone; its main drawback is prominent gastrointestinal gas and bloating.

01 Overview

Acarbose competitively inhibits intestinal alpha-glucosidase enzymes, delaying breakdown of complex carbohydrates and sucrose so glucose is absorbed more slowly and lower down the gut. It is an approved antidiabetic and has data suggesting cardiovascular benefit and even longevity signals in animals.

Physique users take it before carb-heavy meals to flatten glucose and insulin excursions and limit fat storage. Because undigested carbohydrate reaches the colon, flatulence, bloating and loose stools are very common and dose-limiting.

02 Mechanism

Competitively inhibits intestinal brush-border alpha-glucosidases (and pancreatic alpha-amylase), slowing conversion of complex carbohydrates and disaccharides to absorbable monosaccharides, thereby reducing post-prandial glucose and insulin.

03 Dosing

TierDoseRouteNotes
Carb management (off-label)25–100 mgOralBefore high-carbohydrate meals
Diabetes25–100 mgOralWith the first bite of each main meal; up to 3x daily

04 Effects

EffectMagnitudeEvidence
Blunted post-meal glucose/insulinSlows carbohydrate absorption, flattening glucose and insulin excursions.Lower post-prandial spikesClinical
Reduced fat storage from carb mealsLower insulin peaks may reduce fat deposition after large carbohydrate loads.Observational

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Flatulence and GI distressMarked gas, bloating, abdominal cramps and loose stools.MildVery commonClinical
Hypoglycaemia when combined with insulinLow blood glucose only when stacked with insulin or secretagogues.ModerateUncommonClinical

07 References

Acarbose for prevention and management of type 2 diabetes (STOP-NIDDM)The Lancet, 2002

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.